A phase 3 study of chemotherapy 1 pembrolizumab versus chemotherapy 1 placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590-Trial in progress
dc.contributor.author | Bhagia, P. | |
dc.contributor.author | Zhu, Y. | |
dc.contributor.author | Shah, S. | |
dc.contributor.author | Doi, T. | |
dc.contributor.author | Ozguroglu, M. | |
dc.contributor.author | Kato, K. | |
dc.contributor.author | Shah, M. | |
dc.contributor.author | Enzinger, P. | |
dc.contributor.author | Bennouna, J. | |
dc.contributor.author | Shen, L. | |
dc.contributor.author | Adenis, A. | |
dc.contributor.author | Sun, J. | |
dc.contributor.author | Cho, B. | |
dc.contributor.author | Kojima, K. | |
dc.contributor.author | Kostorov, V. | |
dc.contributor.author | Hierro, C. | |
dc.date.accessioned | 2021-03-05T13:25:15Z | |
dc.date.available | 2021-03-05T13:25:15Z | |
dc.identifier.citation | Kato K., Shah M., Enzinger P., Bennouna J., Shen L., Adenis A., Sun J., Cho B., Ozguroglu M., Kojima K., et al., "A phase 3 study of chemotherapy 1 pembrolizumab versus chemotherapy 1 placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590-Trial in progress", ESMO 20th World Congress on Gastrointestinal Cancer, Barcelona, İspanya, 20 - 23 Haziran 2018, cilt.29 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b22440a2-4f96-4403-b69b-1962347fddbc | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/118673 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.title | A phase 3 study of chemotherapy 1 pembrolizumab versus chemotherapy 1 placebo as first-line therapy for patients with advanced esophageal or esophagogastric junction (E/EGJ) cancer: KEYNOTE-590-Trial in progress | |
dc.type | Bildiri | |
dc.contributor.department | National Cancer Center - Japan , , | |
dc.identifier.volume | 29 | |
dc.contributor.firstauthorID | 153844 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]